RAIN
Rain Oncology Inc. Common Stock
RAIN
RAIN
Delisted
RAIN was delisted on the 25th of January, 2024.
46 hedge funds and large institutions have $169M invested in Rain Oncology Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+8
Holders Change %
+21.05%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
12
Increased
15
Reduced
10
Closed
4
Calls
$11K
Puts
$1K
Net Calls
+$10K
Net Calls Change
+$10K
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$22.4M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$7.78M |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$5.6M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.22M |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
+$5.17M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$2.67M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.59M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.37M |
| 4 |
BlackRock
New York
|
-$708K |
| 5 |
E
Ergoteles
New York
|
-$318K |
